Dapagliflozin Reduces Ambulatory Arterial Stiffness Index in CKD Patients with and Without Diabetes Independently of Blood Pressure Control: Results from the GLUcose Transport and Renal PROtection in Chronic Kidney Disease (GLUTREPRO) Trial.
第一作者:
Elisa,Russo
第一单位:
Department of Internal Medicine, University of Genoa, Genoa, Italy.;Nephrology, dialysis and transplantation Unit, IRCCS Policlinico San Martino, Genova, Italy.
作者:
医学主题词
人类(Humans);二苯甲基化合物(Benzhydryl Compounds);葡糖苷类(Glucosides);男(雄)性(Male);女(雌)性(Female);中年人(Middle Aged);肾功能不全, 慢性(Renal Insufficiency, Chronic);治疗结果(Treatment Outcome);血压监测, 便携式(Blood Pressure Monitoring, Ambulatory);老年人(Aged);时间因素(Time Factors);白蛋白尿(Albuminuria);血糖(Blood Glucose);血压(Blood Pressure);肾小球滤过率(Glomerular Filtration Rate);高血压(Hypertension);肾(Kidney)
DOI
10.1007/s40292-025-00764-3
PMID
41366613
发布时间
2026-02-11
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



